| Literature DB >> 16845213 |
Damian Kuc1, Mansur Rahnama, Tomasz Tomaszewski, Wojciech Rzeski, Katarzyna Wejksza, Teresa Urbanik-Sypniewska, Jolanta Parada-Turska, Marian Wielosz, Waldemar A Turski.
Abstract
Kynurenic acid (KYNA) is an endogenous antagonist of alpha7 nicotinic receptors and all ionotropic glutamate receptors. Its neuroprotective activity has been suggested. In this study, the presence of KYNAin human saliva and its potential bactericidal role was investigated. KYNAwas found in all samples of human saliva with mean concentration of 3.4 nM. The concentration of KYNA in saliva obtained from patients with odontogenic abscesses was 3.5 times higher than in healthy subjects. We have shown that the human gingival fibroblasts produce KYNAand an inflammatory stimulant, lipopolysaccharide, enhanced its synthesis in vitro. The bactericidal effect of KYNA was also presented. We hypothesize that KYNA may contribute to the control of oral microflora.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16845213
Source DB: PubMed Journal: Pharmacol Rep ISSN: 1734-1140 Impact factor: 3.024